arrow
J

Johnstone Kumwenda

University of Malawi
H指数:51
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings
2022-07-031
OAAI
Evaluation of Phylogenetic Methods for Inferring the Direction of Human Immunodeficiency Virus (HIV) Transmission: HIV Prevention Trials Network (HPTN) 052
2020-02-0717
OAAI
Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings

在各种资源有限的环境中开始抗逆转录病毒治疗之前和之后,人类免疫缺陷病毒1型阳性个体的远端感觉周围神经病变

2019-08-128
OAAI
Phylogenetic Methods Inconsistently Predict the Direction of HIV Transmission Among Heterosexual Pairs in the HPTN 052 Cohort
2018-12-2415
OAAI
Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited Settings
2018-09-1314
OAAI
Human Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased Neurological Dysfunction
2018-08-2014
OAAI
Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults
AIDS
IF3.1
2017-10-2344
OAAI
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
2016-09-011.1K
OAAI
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial

在开始抗逆转录病毒治疗的晚期HIV成年门诊患者中,经验性结核病治疗与异烟肼治疗的比较 (记住): 一项多国家开放标签随机对照试验

LANCET
IF88.5
2016-03-0169
OAAI
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial

治疗前HIV耐药性和HIV-1亚型C与病毒学失败独立相关: 来自多国PEARLS (ACTG A5175) 临床试验的结果

2015-02-1374
OAAI
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
2014-04-01441
OAAI
Undisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052)
2013-08-0167
OAAI